American Century Companies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $289M | Sell |
580,901
-232,384
| -29% | -$103M | 0.13% | 119 |
|
|
2026
Q1 | $363M | Sell |
813,285
-35,354
| -4% | -$16.5M | 0.19% | 65 |
|
|
2025
Q4 | $385M | Buy |
848,639
+399,446
| +89% | +$172M | 0.19% | 65 |
|
|
2025
Q3 | $176M | Sell |
449,193
-88,939
| -17% | -$37.2M | 0.09% | 210 |
|
|
2025
Q2 | $240M | Buy |
538,132
+72,391
| +16% | +$33.4M | 0.13% | 145 |
|
|
2025
Q1 | $226M | Sell |
465,741
-7,619
| -2% | -$3.55M | 0.14% | 127 |
|
|
2024
Q4 | $191M | Sell |
473,360
-11,453
| -2% | -$5.31M | 0.11% | 163 |
|
|
2024
Q3 | $225M | Sell |
484,813
-101,509
| -17% | -$48.8M | 0.13% | 138 |
|
|
2024
Q2 | $275M | Sell |
586,322
-108,572
| -16% | -$47.1M | 0.17% | 97 |
|
|
2024
Q1 | $290M | Sell |
694,894
-105,643
| -13% | -$44.7M | 0.18% | 94 |
|
|
2023
Q4 | $326M | Sell |
800,537
-144,331
| -15% | -$53.3M | 0.22% | 79 |
|
|
2023
Q3 | $329M | Sell |
944,868
-56,562
| -6% | -$19.8M | 0.25% | 75 |
|
|
2023
Q2 | $352M | Sell |
1,001,430
-149,472
| -13% | -$50.4M | 0.27% | 68 |
|
|
2023
Q1 | $362M | Buy |
1,150,902
+19,887
| +2% | +$5.96M | 0.29% | 70 |
|
|
2022
Q4 | $327M | Sell |
1,131,015
-129,082
| -10% | -$39.3M | 0.27% | 89 |
|
|
2022
Q3 | $365M | Buy |
1,260,097
+80,563
| +7% | +$23.2M | 0.32% | 64 |
|
|
2022
Q2 | $332M | Buy |
1,179,534
+78,659
| +7% | +$21.1M | 0.27% | 85 |
|
|
2022
Q1 | $287M | Buy |
1,100,875
+476,422
| +76% | +$113M | 0.2% | 124 |
|
|
2021
Q4 | $137M | Sell |
624,453
-145,053
| -19% | -$28.2M | 0.09% | 243 |
|
|
2021
Q3 | $140M | Sell |
769,506
-130,754
| -15% | -$25.5M | 0.1% | 213 |
|
|
2021
Q2 | $182M | Buy |
900,260
+183,075
| +26% | +$38.3M | 0.12% | 179 |
|
|
2021
Q1 | $154M | Sell |
717,185
-214,647
| -23% | -$47.1M | 0.11% | 212 |
|
|
2020
Q4 | $220M | Sell |
931,832
-96,336
| -9% | -$22.1M | 0.17% | 149 |
|
|
2020
Q3 | $280M | Buy |
1,028,168
+214,855
| +26% | +$59.3M | 0.25% | 103 |
|
|
2020
Q2 | $236M | Sell |
813,313
-285,928
| -26% | -$77.5M | 0.22% | 124 |
|
|
2020
Q1 | $262M | Sell |
1,099,241
-26,623
| -2% | -$6.11M | 0.31% | 85 |
|
|
2019
Q4 | $247M | Buy |
1,125,864
+135,987
| +14% | +$27.5M | 0.23% | 128 |
|
|
2019
Q3 | $168M | Buy |
989,877
+68,701
| +7% | +$12.2M | 0.17% | 166 |
|
|
2019
Q2 | $169M | Buy |
921,176
+11,067
| +1% | +$1.93M | 0.17% | 174 |
|
|
2019
Q1 | $167M | Sell |
910,109
-49,448
| -5% | -$9.13M | 0.17% | 172 |
|
|
2018
Q4 | $159M | Sell |
959,557
-188,868
| -16% | -$32.7M | 0.18% | 162 |
|
|
2018
Q3 | $221M | Buy |
1,148,425
+22,997
| +2% | +$4.1M | 0.22% | 135 |
|
|
2018
Q2 | $191M | Buy |
1,125,428
+879,411
| +357% | +$136M | 0.19% | 160 |
|
|
2018
Q1 | $40.1M | Buy |
246,017
+67,911
| +38% | +$11.1M | 0.04% | 391 |
|
|
2017
Q4 | $26.7M | Buy |
178,106
+14,560
| +9% | +$2.16M | 0.03% | 471 |
|
|
2017
Q3 | $24.9M | Sell |
163,546
-60,807
| -27% | -$9.15M | 0.03% | 482 |
|
|
2017
Q2 | $28.9M | Buy |
224,353
+63,854
| +40% | +$7.69M | 0.03% | 457 |
|
|
2017
Q1 | $17.6M | Sell |
160,499
-129,475
| -45% | -$11.4M | 0.02% | 557 |
|
|
2016
Q4 | $21.4M | Sell |
289,974
-442,629
| -60% | -$36M | 0.02% | 517 |
|
|
2016
Q3 | $63.9M | Sell |
732,603
-585,251
| -44% | -$55.3M | 0.07% | 324 |
|
|
2016
Q2 | $113M | Sell |
1,317,854
-438,168
| -25% | -$37.9M | 0.13% | 217 |
|
|
2016
Q1 | $140M | Buy |
1,756,022
+245,477
| +16% | +$22.2M | 0.16% | 181 |
|
|
2015
Q4 | $190M | Buy |
1,510,545
+300,457
| +25% | +$36.3M | 0.22% | 125 |
|
|
2015
Q3 | $126M | Buy |
1,210,088
+582,852
| +93% | +$74.9M | 0.15% | 181 |
|
|
2015
Q2 | $77.5M | Sell |
627,236
-40,940
| -6% | -$5.16M | 0.09% | 299 |
|
|
2015
Q1 | $78.8M | Buy |
668,176
+550,634
| +468% | +$66M | 0.09% | 302 |
|
|
2014
Q4 | $14M | Buy |
117,542
+47
| +0% | +$5.29K | 0.02% | 614 |
|
|
2014
Q3 | $13.2M | Sell |
117,495
-29,905
| -20% | -$2.85M | 0.02% | 608 |
|
|
2014
Q2 | $14M | Sell |
147,400
-21,600
| -13% | -$1.51M | 0.02% | 629 |
|
|
2014
Q1 | $12M | Sell |
169,000
-33,186
| -16% | -$2.63M | 0.01% | 665 |
|
|
2013
Q4 | $15M | Sell |
202,186
-179,174
| -47% | -$12.5M | 0.02% | 591 |
|
|
2013
Q3 | $28.9M | Buy |
381,360
+56,188
| +17% | +$4.47M | 0.04% | 448 |
|
|
2013
Q2 | $26M | Buy |
+325,172
| New | +$23.9M | 0.03% | 459 |
|
Other funds holding VRTX
American Century Companies's VRTX Position: Q2 2026 in Review
American Century Companies reduced its Vertex Pharmaceuticals (VRTX) stake by 29% in Q2 2026, selling an estimated $103M and leaving 580,901 shares worth $289M. The position accounts for 0.13% of the portfolio, ranked #119.
American Century Companies first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $385M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- American Century Companies held 580,901 shares of Vertex Pharmaceuticals worth $289M as of Q2 2026.
- American Century Companies sold 232,384 Vertex Pharmaceuticals shares in Q2 2026, an estimated $103M.
- Vertex Pharmaceuticals made up 0.13% of American Century Companies's portfolio in Q2 2026, its #119 holding.
- American Century Companies first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- American Century Companies's Vertex Pharmaceuticals position peaked at $385M in Q4 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.